Key Laboratory of Drug Quality Control and Pharmacovigilance, Ministry of Education, China Pharmaceutical University, Nanjing, P. R. China.
Department of Pharmaceutical Analysis, China Pharmaceutical University, Nanjing, P. R. China.
J Sep Sci. 2019 Aug;42(16):2650-2659. doi: 10.1002/jssc.201900402. Epub 2019 Jun 24.
Mycophenolate mofetil is an antiproliferative immunosuppressive agent. Since its clinical efficacy and safety highly depend on the quality, the stability, and impurity profiles of mycophenolate mofetil are paid ever-increasing attention. However, there are few published studies reporting the complete characterization of both the process-related substances and degradation products in mycophenolate mofetil. In the present study, a highly specific and efficient liquid chromatography coupled with quadrupole-time of flight mass spectrometry method was developed for the separation and identification of all the potential impurities in mycophenolate mofetil. According to the ICH Q1A (R2) guideline, the forced degradation studies were conducted to elucidate the stability and degradation pathways of mycophenolate mofetil. A total of 15 related substances, including the process-related substances and stress degradation products were characterized by the established hyphenated method, 11 of them have not been reported before. In view of the synthetic route and degradation pathways of mycophenolate mofetil, the origins and formation mechanisms of these related substances were discussed. Based on the obtained stability and impurity profiles, key points of the manufacturing process were proposed to deliver mycophenolate mofetil with high purity.
霉酚酸酯是一种抗增殖免疫抑制剂。由于其临床疗效和安全性高度依赖于霉酚酸酯的质量、稳定性和杂质特征,因此对其的关注度日益增加。然而,目前鲜有研究报道完整地描述霉酚酸酯的工艺相关物质和降解产物。在本研究中,建立了一种高特异性和高效的液相色谱-四极杆飞行时间质谱联用方法,用于分离和鉴定霉酚酸酯中的所有潜在杂质。根据 ICH Q1A(R2)指南,进行了强制降解研究以阐明霉酚酸酯的稳定性和降解途径。通过所建立的联用方法,共鉴定了 15 种有关物质,包括工艺相关物质和应激降解产物,其中 11 种尚未有报道。鉴于霉酚酸酯的合成路线和降解途径,讨论了这些有关物质的来源和形成机制。基于获得的稳定性和杂质特征,提出了生产工艺的关键点,以提供高纯度的霉酚酸酯。